Antiplatelet agent causes vasodilator agents. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy10

Blood Platelets Endothelium, Vascular Forearm Coronary Vessels Mesenteric Arteries Vasomotor System Arterioles Arteries Muscle, Smooth, Vascular Pulmonary Artery

Organisms3

Dogs Rabbits Rats, Sprague-Dawley

Diseases28

Thrombosis Hemorrhage Acute Coronary Syndrome Stroke Coronary Thrombosis Thromboembolism Postoperative Hemorrhage Myocardial Infarction Intracranial Hemorrhages Ischemic Attack, Transient Recurrence Cerebrovascular Disorders Coronary Artery Disease Cerebral Hemorrhage Brain Ischemia Peripheral Vascular Diseases Cardiovascular Diseases Coronary Disease Atrial Fibrillation Myocardial Ischemia Postoperative Complications Hyperemia Hypertension, Pulmonary Thrombocytopenia Purpura, Thrombocytopenic Intracranial Thrombosis Hypertension Embolism

Chemicals and Drugs70

Vasodilator Agents Platelet Aggregation Inhibitors Papaverine Aspirin Nitroprusside Ticlopidine Acetylcholine Thienopyridines Dipyridamole Anticoagulants Purinergic P2Y Receptor Antagonists Thiophenes Receptors, Purinergic P2Y12 Fibrinolytic Agents Dilazep Platelet Glycoprotein GPIIb-IIIa Complex Warfarin Phosphodiesterase 3 Inhibitors Purinergic P2 Receptor Antagonists Tetrazoles Piperazines Adenosine Cardiovascular Agents Immunoglobulin Fab Fragments Adenosine Diphosphate Vitamin K Nitric Oxide Pyridines Phenprocoumon Heparin Receptor, PAR-1 Angiotensin-Converting Enzyme Inhibitors Nitroglycerin Adrenergic beta-Antagonists Hydroxymethylglutaryl-CoA Reductase Inhibitors Epoprostenol Thrombin Hydralazine Bradykinin Thromboxane B2 NG-Nitroarginine Methyl Ester Collagen Calcitonin Gene-Related Peptide Vasoconstrictor Agents Cyclooxygenase Inhibitors Antibodies, Monoclonal omega-N-Methylarginine Nitric Oxide Synthase Arginine Thromboxane A2 Endothelium-Dependent Relaxing Factors Sulfinpyrazone Thromboxanes Antihypertensive Agents Adrenomedullin Alprostadil Cromakalim Enzyme Inhibitors Indomethacin Nitroarginine Cyclic GMP Minoxidil Isosorbide Dinitrate Phenazopyridine Biological Factors Nitroso Compounds Acenocoumarol Prostaglandins Benzopyrans 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid

Analytical, Diagnostic and Therapeutic Techniques and Equipment26

Platelet Function Tests Bleeding Time Drug Therapy, Combination Treatment Outcome Stents Risk Factors Angioplasty, Balloon, Coronary Perioperative Care Administration, Oral Risk Assessment Follow-Up Studies Prospective Studies Retrospective Studies Thrombolytic Therapy Randomized Controlled Trials as Topic Clinical Trials as Topic Double-Blind Method Registries Incidence Blood Pressure Drug-Eluting Stents Platelet Count Plethysmography Percutaneous Coronary Intervention Coronary Angiography Heart Rate

Phenomena and Processes21

Vasodilation Vascular Resistance Platelet Aggregation Bleeding Time Platelet Activation Dose-Response Relationship, Drug Time Factors Platelet Adhesiveness Drug Resistance Regional Blood Flow Hemodynamics Blood Pressure Vasoconstriction Platelet Count Coronary Circulation Pulmonary Circulation Splanchnic Circulation Drug Interactions Microcirculation Renal Circulation Heart Rate

Information Science2

Registries Incidence

Health Care14

Treatment Outcome Secondary Prevention Risk Factors Perioperative Care Risk Assessment Follow-Up Studies Prospective Studies Retrospective Studies Randomized Controlled Trials as Topic Clinical Trials as Topic Double-Blind Method Practice Guidelines as Topic Registries Incidence

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Phenomena and Processes Information Science Health Care

Vasodilator Agents Platelet Aggregation Inhibitors Papaverine Aspirin Nitroprusside Ticlopidine Vasodilation Acetylcholine Vascular Resistance Platelet Aggregation Thrombosis Thienopyridines Dipyridamole Platelet Function Tests Hemorrhage Anticoagulants Purinergic P2Y Receptor Antagonists Bleeding Time Thiophenes Blood Platelets Receptors, Purinergic P2Y12 Drug Therapy, Combination Fibrinolytic Agents Platelet Activation Dilazep Platelet Glycoprotein GPIIb-IIIa Complex Acute Coronary Syndrome Stroke Warfarin Treatment Outcome Phosphodiesterase 3 Inhibitors Coronary Thrombosis Thromboembolism Secondary Prevention Purinergic P2 Receptor Antagonists Stents Tetrazoles Risk Factors Postoperative Hemorrhage Piperazines Adenosine Angioplasty, Balloon, Coronary Cardiovascular Agents Perioperative Care Immunoglobulin Fab Fragments Adenosine Diphosphate Myocardial Infarction Administration, Oral Dose-Response Relationship, Drug Intracranial Hemorrhages Ischemic Attack, Transient Recurrence Cerebrovascular Disorders Time Factors Platelet Adhesiveness Vitamin K Nitric Oxide Pyridines Coronary Artery Disease Cerebral Hemorrhage Risk Assessment Phenprocoumon Follow-Up Studies Prospective Studies Brain Ischemia Peripheral Vascular Diseases Retrospective Studies Heparin Receptor, PAR-1 Cardiovascular Diseases Drug Resistance Angiotensin-Converting Enzyme Inhibitors Nitroglycerin Regional Blood Flow Thrombolytic Therapy Randomized Controlled Trials as Topic Adrenergic beta-Antagonists Clinical Trials as Topic Double-Blind Method Coronary Disease Atrial Fibrillation Endothelium, Vascular Forearm Hydroxymethylglutaryl-CoA Reductase Inhibitors Epoprostenol Practice Guidelines as Topic Thrombin Hydralazine Registries Hemodynamics Myocardial Ischemia Bradykinin Incidence Blood Pressure Vasoconstriction Drug-Eluting Stents Coronary Vessels Thromboxane B2 NG-Nitroarginine Methyl Ester Postoperative Complications

No FAQ available that match "antiplatelet agent causes vasodilator agents"